Form 4 for ELAN Elanco Animal Health Inc
Accepted 2025-03-05 00:00:00 ET · period of report 2025-03-03 · accession 0001415889-25-007082 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-05 | 2025-03-03 | ELAN | Simmons Jeffrey N | Pres, CEO AND Dir, Dir | A - Grant | $0.00 | +265.3K | 1.80M | +17% | $0 |
| DM | 2025-03-05 | 2025-03-03 | ELAN | Simmons Jeffrey N | Pres, CEO AND Dir, Dir | A - Grant | $0.00 | +571.5K | 14.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-03 | A | A | 265,252 | $0.00 | 1,802,379 | D | — | — | (F1) Grant of restricted stock units vesting as follows: one-third vesting on March 3, 2026, one-third vesting on March 3, 2027, and the remaining vesting on March 3, 2028. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2025-03-03 | A | A | 556,587 | $0.00 | 556,587 | D | $11.31 · — to 2035-03-03 | 556,587 Common Stock | (F2) Grant of stock options vesting as follows: one-third vesting on March 3, 2026, one-third vesting on March 3, 2027, and the remaining vesting on March 3, 2028. |
| 3 | Derivative | Deferred Stock Units (Match) | 2025-03-03 | A | A | 14,891 | $0.00 | 14,891 | D | — · — to — | 14,891 Common Stock | (F3) Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. (F4) Deferred stock units vest December 31, 2026 and settle upon termination of employment or otherwise in accordance with the Executive Deferral and Stock Match Plan. |